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ABSTRACT 
TITLE OF THE STUDY: 
“Safety and Efficacy of Dexmedetomidine on patients undergoing 
General Anaesthesia: A single-blinded, randomized clinical trial’’. 
BACKGROUND AND OBJECTIVES:  
Laryngoscopy and endotracheal intubation is to be done during general 
anesthesia. Succinyl choline is administered just before intubation .This can 
lead to an increase in intra ocular pressure, heart rate and blood pressure. 
Succinyl choline is associated with rise in IOP which is harmful in open eye 
injuries. Various drugs have been used to reduce this stress response. 
Dexmedetomidine is an alpha2 adrenergic agonist which has sedative, 
anxiolytic and analgesic properties
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METHODS: 
After approval of institutional ethical committee, a total of 60 patients 
of ASA 1and 2 were enrolled in this study with written informed consent. 
Half the patients received i.v Dexmedetomidine 0.6µg/kg bolus over 10 
minutes and the remaining half received same volume of normal saline 
similarly. Intra ocular pressure, Heart rate, mean arterial pressures and 
sedation scores were recorded periodically. 
STATISTICAL ANALYSIS: 
 The data was analysed by SPSS 17.0 with independent t-test. 
RESULTS: 
In this single-blinded randomized study, two groups were compared for 
changes in IOP, HR, MAP and sedation. The group, where the selected dose of 
dexmedetomidine was administered resulted in a significant reduction in IOP 
and prevented the rise in the IOP in response to intubation. In addition, the 
pressor response to laryngoscopy and endotracheal intubation was also 
significantly attenuated. Higher doses of dexmedetomidine were associated 
with an additional reduction in arterial pressure and HR without any further 
decrease in IOP
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Some authors find that the use of succinylcholine in open 
ocular trauma is controversial and an alternative anaesthetic management based 
on the use of non-depolarizing neuromuscular blocking agents, despite its 
slower onset, was suggested. To conclude, the rise of IOP with succinycholine 
and endotracheal intubation can be blunted with i.v. dexmedetomidine 
premedication the haemodynamic stability is an additional advantage. 
IMPRESSION: 
Premedication with intravenous Dexmedetomidine under the dose given in 
the present study design attenuates the rise in intraocular pressure following 
succinylcholine and intubation. The attenuation of haemodynamic stress response to 
laryngoscopy and intubation is an additional advantage. Hence dexmedetomidine 
should be used as a premedicant in situation where an increase in intraocular 
pressure following succinylcholine and intubation is detrimental for patients.
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